Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

WAYNE MEMORIAL HOSPITAL INC

NPI: 1750353462 · GOLDSBORO, NC 27534 · General Acute Care Hospital · NPI assigned 02/06/2006

$37.84M
Total Medicaid Paid
724,199
Total Claims
601,355
Beneficiaries
159
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialTHOMA, WILLIAM (SR VICE PRESIDENT, FINANCE / CFO)
NPI Enumeration Date02/06/2006

Related Entities

Other providers sharing the same authorized official: THOMA, WILLIAM

ProviderCityStateTotal Paid
WAYNE MEMORIAL HOSPITAL GOLDSBORO NC $41K
WAYNE MEMORIAL HOSPITAL GOLDSBORO NC $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 92,351 $3.42M
2019 99,347 $4.05M
2020 66,545 $2.37M
2021 96,063 $5.31M
2022 117,725 $7.62M
2023 136,943 $8.24M
2024 115,225 $6.83M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 41,860 38,513 $8.97M
99283 Emergency department visit for the evaluation and management, moderate severity 56,822 52,901 $7.93M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 23,323 21,319 $5.31M
41899 Unlisted procedure, dentoalveolar structures 1,901 1,639 $3.26M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 32,393 26,859 $1.28M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 7,133 6,589 $971K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 8,972 8,168 $767K
99282 Emergency department visit for the evaluation and management, low to moderate severity 9,369 8,866 $765K
0202U Oncology (prostate), multianalyte, gene expression profiling 8,094 7,080 $762K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 11,572 10,633 $713K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 9,317 5,773 $602K
J3490 Unclassified drugs 92,373 44,723 $576K
96375 Therapeutic injection; each additional sequential IV push 4,301 3,842 $501K
80053 Comprehensive metabolic panel 58,243 53,068 $468K
74177 Computed tomography, abdomen and pelvis; with contrast material 406 363 $433K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 59,870 54,514 $432K
71046 Radiologic examination, chest; 2 views 13,665 12,714 $431K
T1016 Case management, each 15 minutes 1,970 1,463 $417K
70450 Computed tomography, head or brain; without contrast material 2,093 1,938 $407K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,693 6,904 $376K
96361 Intravenous infusion, hydration; each additional hour 6,547 5,724 $263K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3,367 3,075 $233K
81001 46,819 42,818 $154K
36415 Collection of venous blood by venipuncture 68,304 60,505 $151K
84484 19,164 15,309 $140K
97597 2,852 1,790 $121K
71045 Radiologic examination, chest; single view 4,940 4,509 $83K
84443 Thyroid stimulating hormone (TSH) 3,472 3,168 $75K
87150 2,070 1,875 $66K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,281 1,996 $62K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 769 243 $60K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3,507 3,173 $60K
87086 Culture, bacterial; quantitative colony count, urine 7,245 6,616 $60K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2,567 2,348 $55K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,675 1,501 $54K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,675 1,501 $54K
83690 6,295 5,776 $47K
81025 5,564 5,169 $45K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 396 359 $43K
J7030 Infusion, normal saline solution , 1000 cc 4,743 4,132 $43K
84703 4,534 4,134 $42K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 215 187 $27K
29580 418 179 $26K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 148 140 $23K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 23 13 $20K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,160 1,080 $19K
82553 3,487 3,112 $19K
J7120 Ringers lactate infusion, up to 1000 cc 2,389 1,830 $18K
80306 698 655 $17K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,637 1,371 $17K
Q3014 Telehealth originating site facility fee 569 402 $17K
88305 Level IV - Surgical pathology, gross and microscopic examination 270 230 $16K
J1885 Injection, ketorolac tromethamine, per 15 mg 3,896 3,536 $14K
81513 1,207 1,071 $14K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 89 51 $13K
82550 3,729 3,338 $12K
J2704 Injection, propofol, 10 mg 3,438 2,964 $12K
J3010 Injection, fentanyl citrate, 0.1 mg 2,137 1,767 $11K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 264 250 $10K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 123 114 $10K
83605 1,347 1,144 $10K
72125 Computed tomography, cervical spine; without contrast material 36 36 $10K
80061 Lipid panel 540 519 $9K
85027 1,445 1,342 $9K
29581 160 81 $9K
J2250 Injection, midazolam hydrochloride, per 1 mg 2,015 1,655 $8K
95810 Polysomnography; sleep staging with 4 or more additional parameters 12 12 $8K
84439 703 679 $8K
83036 Hemoglobin; glycosylated (A1C) 662 633 $8K
82962 4,152 3,347 $8K
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,078 2,609 $7K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 1,987 1,718 $7K
85610 2,405 2,163 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,813 1,555 $7K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 15 12 $6K
0012A 101 101 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 306 283 $5K
87081 603 566 $5K
J0330 Injection, succinylcholine chloride, up to 20 mg 959 827 $5K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 143 130 $5K
0011A 107 105 $4K
94664 553 511 $4K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 371 308 $4K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 136 121 $4K
80051 456 436 $4K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 69 52 $3K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 25 24 $3K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 123 113 $3K
J8597 Antiemetic drug, oral, not otherwise specified 237 201 $3K
86850 183 167 $3K
84702 222 204 $3K
86780 132 120 $3K
93320 25 24 $2K
87040 189 149 $2K
87088 336 326 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 46 45 $2K
83735 392 360 $2K
84460 459 450 $2K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 862 746 $2K
83880 115 104 $2K
87186 242 217 $2K
86803 109 103 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor 35 33 $2K
J0736 Injection, clindamycin phosphate, 300 mg 69 59 $2K
83615 222 182 $2K
82570 222 182 $2K
J7050 Infusion, normal saline solution, 250 cc 840 251 $1K
V2632 Posterior chamber intraocular lens 75 39 $1K
93325 25 24 $1K
84550 224 184 $1K
80048 Basic metabolic panel (calcium, ionized) 191 163 $1K
86762 67 63 $1K
84156 221 181 $1K
86787 69 65 $1K
85730 171 155 $941.14
86677 144 121 $914.72
J2270 Injection, morphine sulfate, up to 10 mg 164 138 $882.01
86901 241 215 $849.58
87340 75 71 $808.38
86900 227 202 $805.05
A9270 Non-covered item or service 13,588 5,953 $795.70
82565 274 271 $778.37
74022 12 12 $678.98
J0171 Injection, adrenalin, epinephrine, 0.1 mg 125 84 $569.54
J1097 Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml 13 12 $519.63
86592 106 101 $472.59
J7060 5% dextrose/water (500 ml = 1 unit) 62 56 $446.40
87077 62 59 $414.65
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 18 12 $400.23
87210 94 81 $390.04
87420 27 27 $385.56
J0690 Injection, cefazolin sodium, 500 mg 511 388 $364.19
97605 19 12 $357.10
83021 13 12 $329.40
J2540 Injection, penicillin g potassium, up to 600,000 units 62 56 $322.57
86696 15 13 $319.98
86701 33 31 $309.68
85660 55 52 $309.60
J0696 Injection, ceftriaxone sodium, per 250 mg 146 137 $297.75
86695 15 13 $217.88
J7510 Prednisolone oral, per 5 mg 49 48 $212.80
87350 16 14 $203.29
J2003 Injection, lidocaine hydrochloride, 1 mg 32 28 $184.01
C9447 Injection, phenylephrine and ketorolac, 4 ml vial 31 12 $171.09
86141 12 12 $137.19
82950 25 24 $124.32
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 43 39 $122.89
87070 30 27 $117.26
J1644 Injection, heparin sodium, per 1000 units 67 40 $85.31
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 29 29 $81.37
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 25 25 $77.47
84520 235 232 $62.37
86140 16 14 $47.39
82948 20 18 $46.53
87205 28 25 $44.94
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 659 484 $5.66
80143 14 12 $0.00
P9612 Catheterization for collection of specimen, single patient, all places of service 197 180 $0.00
91301 215 204 $0.00